1. Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU‐285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies. (15th July 2019) Authors: Weisberg, Ellen; Meng, Chengcheng; Case, Abigail E.; Sattler, Martin; Tiv, Hong L.; Gokhale, Prafulla C.; Buhrlage, Sara J.; Liu, Xiaoxi; Yang, Jing; Wang, Jinhua; Gray, Nathanael; Stone, Richard M.; Adamia, Sophia; Dubreuil, Patrice; Letard, Sebastien; Griffin, James D. Journal: British journal of haematology Issue: Volume 187:Number 4(2019) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of the multi‐kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia. Issue 5 (22nd January 2020) Authors: Weisberg, Ellen; Meng, Chengcheng; Case, Abigail E.; Tiv, Hong L.; Gokhale, Prafulla C.; Buhrlage, Sara J.; Yang, Jing; Liu, Xiaoxi; Wang, Jinhua; Gray, Nathanael; Adamia, Sophia; Sattler, Martin; Stone, Richard; Griffin, James D. Journal: Journal of cellular and molecular medicine Issue: Volume 24:Issue 5(2020) Page Start: 2968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations. Issue 3 (14th January 2020) Authors: Weisberg, Ellen; Meng, Chengcheng; Case, Abigail E.; Tiv, Hong L.; Gokhale, Prafulla C.; Toure, Anthia A.; Buhrlage, Sara; Liu, Xiaoxi; Wang, Jinhua; Gray, Nathanael; Stone, Richard; Adamia, Sophia; Winer, Eric; Sattler, Martin; Griffin, James D. Journal: Journal of cellular and molecular medicine Issue: Volume 24:Issue 3(2020) Page Start: 2145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗